|
|
|
|
||
|
||
|
|
||
| SEARCH | SUBSCRIBE | ||
Some related articles : China Wants to Set Drug-Price Caps, Angering Pharmaceutical Companies (December 3, 2001) |
 |
Merck
Cuts Price for AIDs Drugs It Sells in China by About a Third
By
Leslie Chang
The
Wall Street Journal, December 3, 2001
BEIJING – Merck & Co. is cutting prices for two AIDS drugs it sells in China, a first for a country that is only starting to face up to its burgeoning epidemic. The U.S. pharmaceutical maker said it will cut by a third the wholesale prices for two of its drugs, Crixivan and Stocrin. At retail prices, Merck’s move means that a year’s supply of the two medicines will cost about $3,500, down from the original $10,000, the company said. (See related article.) The announcement, effective immediately, is the first to come out of recent talks between drug companies and the Chinese government, and follows similar moves by pharmaceutical companies in other developing nations. Until now, the Chinese government has been less aggressive than the governments of other nations, among them Brazil and South Africa, in publicly challenging the pharmaceutical industry to bring its drug prices into reach for most patients. The moves are a step toward helping patients gain access to the drugs in China. While estimates of Chinese people infected with HIV, the virus that causes AIDS, reach about a million, many of those don’t know they are infected, and few can afford the drugs at full price. “Our goal is to spur efforts to accelerate access to these life-saving medications in China, where the HIV/AIDS epidemic will become a widespread and devastating toll on the lives of those living with HIV, their families and their communities,” said Douglas Cheung, managing director of Merck Sharp & Dohme (China) Ltd.
.
FAIR USE NOTICE: This page contains copyrighted material the use of which has not been specifically authorized by the copyright owner. Global Action on Aging distributes this material without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. We believe this constitutes a fair use of any such copyrighted material as provided for in 17 U.S.C § 107. If you wish to use copyrighted material from this site for purposes of your own that go beyond fair use, you must obtain permission from the copyright owner.
|
